Cybersecurity & Cloud Systems

Cloud-Based Systems for Medical Devices: FDA Perspective

April 22, 2024
|
By Dr. Ebot Eyong

The FDA advocates adopting cloud-based systems for medical devices, highlighting benefits such as scalability, enhanced security, collaboration, innovation potential, and operational cost savings. This article explains FDA perspectives and best practices for cloud-based medical device systems.

Overview

The FDA advocates adopting cloud-based systems for medical devices, highlighting key benefits such as scalability, enhanced security, and innovation potential. Utilizing cloud solutions can improve patient care, simplify regulatory compliance, and help reduce operational expenses.

Advantages of Cloud-Based Systems in Medical Devices

  • Scalability and Flexibility: Cloud solutions are designed to manage large volumes of data and can scale resources as necessary, adapting to the evolving needs of healthcare organizations.
  • Enhanced Security: Cloud platforms incorporate security measures like encryption and access controls to protect sensitive patient and device data.
  • Improved Collaboration: These systems facilitate seamless data sharing among healthcare professionals, enabling better coordination and decision-making.
  • Cost Savings: By reducing the need for on-premises infrastructure and ongoing maintenance, cloud solutions help organizations save money.

FDA Guidance on Cloud-Based Medical Devices

  • Premarket Cybersecurity Guidance: The FDA emphasizes cybersecurity throughout the design phase of medical devices, especially those that use cloud-based systems.
  • Post-Market Surveillance: Manufacturers are required to monitor and report cybersecurity vulnerabilities and incidents related to their devices after they have reached the market.

Best Practices for Implementing Cloud-Based Medical Devices

  • Choose a Secure Cloud Platform: Select a cloud platform that complies with FDA regulations and offers robust security features.
  • Implement Cybersecurity Measures: Ensure that cloud-based systems incorporate adequate protection mechanisms, such as encryption and access controls.
  • Perform Regular Security Audits: Conduct consistent reviews of cloud-based systems to identify and address potential security vulnerabilities.

For more information, visit https://eemedicals.com/

Explore More Publications

Continue exploring Dr. Ebot Eyong’s professional insights on healthcare regulation, FDA submissions, AI-enabled medical devices, quality systems, and global compliance strategy.

EU Regulatory Strategy

EU Proposal to Revise MDR and IVDR: Implications for Innovation, Documentation, and Software Oversight

February 17, 2026
|
By Dr. Ebot Eyong

The European Commission has proposed a targeted revision of the Medical Device Regulation and In Vitro Diagnostic Regulation aimed at supporting innovation while reducing unnecessary administrative burden. This article explores the impact on technical documentation, manufacturers, implementation challenges, and software oversight.

Read Article

Global Regulatory Strategy

One Medical Device, Multiple Regulatory Frameworks

August 10, 2024
|
By Dr. Ebot Eyong

A medical device may be engineered to a single design specification and validated to the same performance standards globally, but its regulatory pathway varies significantly depending on the market in which it is placed.

Read Article

Software & SaMD

FDA Draft Guidance on AI-Enabled Device Software: Key Takeaways for Industry

September 2, 2025
|
By Dr. Ebot Eyong

On January 6, 2025, the FDA released draft guidance on development, lifecycle management, and marketing submissions for AI-enabled device software. This article explains key lifecycle expectations, submission considerations, manufacturer implications, and regulatory pitfalls.

Read Article

CMC & FDA Submissions

FDA Guidance for Chemistry, Manufacturing, and Controls (CMC) Submissions

January 15, 2025
|
By Dr. Ebot Eyong

The FDA provides several guidance documents for Chemistry, Manufacturing, and Controls submissions, including post-approval manufacturing changes, comparability protocols, disposable manufacturing materials, nanomaterials, and current good manufacturing practice requirements for combination products.

Read Article